Guidelines on the management of cholestasis liver diseases (2021).
10.3760/cma.j.cn112138-20211112-00795
- Collective Name:Chinese Society of Hepatology, Chinese Medical Association
- Publication Type:Journal Article
- MeSH:
Autoimmune Diseases/diagnosis*;
Cholestasis/therapy*;
Consensus;
Gastroenterology;
Humans;
Liver Diseases/therapy*
- From:
Chinese Journal of Hepatology
2022;30(3):253-263
- CountryChina
- Language:Chinese
-
Abstract:
In 2015, the Chinese Society of Hepatology and Chinese Society of Gastroenterology issued the consensus on the diagnosis and management of cholestatic liver diseases. In the past years, more data have emerged from clinical practice. Herein, the Autoimmune Liver Disease Group of the Chinese Society of Hepatology organized an expert group to review the evidence and updated the recommendations to formulate the guidelines. There are 22 recommendations on clinical practice of cholestatic liver diseases. The guidelines aim to provide a working reference for the management of cholestatic liver diseases.
